These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prevalence of vitiligo among type 2 diabetic patients in an Iranian population.
    Author: Afkhami-Ardekani M, Ghadiri-Anari A, Ebrahimzadeh-Ardakani M, Zaji N.
    Journal: Int J Dermatol; 2014 Aug; 53(8):956-8. PubMed ID: 24134629.
    Abstract:
    BACKGROUND: Vitiligo is one of many diseases that can be found with diabetes mellitus. Diabetic patients have a high incidence of vitiligo compared to the general population. This study assesses prevalence of vitiligo in type 2 diabetic patients in Iran. METHODS: One thousand one hundred type 2 diabetic patients and 1100 healthy adults were recruited in this cross-sectional study. Patients were evaluated for vitiligo by a dermatologist both clinically and by Wood's lamp. Data were analyzed using SPSS. P value ≤0.05 was considered statistically significant. RESULTS: There was a significant difference between groups with respect to presence of vitiligo; 4.9% of diabetic patients had vitiligo versus 1.8% of control group (P = 0.001). In the female group with diabetes, 5.8% had vitiligo, and in male diabetic patients, 3.9% had vitiligo (P = 0.057). In the control group, 1.8% of females and 1.8% of males had vitiligo that was equal. CONCLUSION: Vitiligo and diabetes may have a causal relationship. Vitiligo may coexist with type 2 diabetes. Therefore it is reasonable to investigate each patient periodically.
    [Abstract] [Full Text] [Related] [New Search]